🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
In this double-blinded randomized clinical trial study, investigators asses...
Status
Completed
Location
CHU de Québec, radio-oncology departement
Start Date
2006-12
Trial ID
NCT01839721
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
Randomized, placebo-controlled trial with a 2x2 factorial design testing th...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2020-09-03
Trial ID
NCT04192136
Treatments Being Tested
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
The aim of this study is to compare and evaluate the effects of using lidoc...
Status
Completed
Location
Pamukkale University Faculty of Dentistry
Start Date
2025-01-01
Trial ID
NCT07145879
The purpose of this study is to assess the safety and tolerability of SF200...
Status
Unknown
Location
Tropical Diseases Resaerch Centre
Start Date
2016-09
Trial ID
NCT02941159
Single Center, Double Blind, Active Comparator Controlled 2-Way Crossover M...
Status
Completed
Location
Atlanta Diabetes Association
Start Date
2017-05-18
Trial ID
NCT03156361
Treatments Being Tested
This study investigates whether four weeks of Rhodiola rosea supplementatio...
Status
Completed
Location
China Football Institute, Beijing Sport University
Start Date
2025-08-30
Trial ID
NCT07366320
Treatments Being Tested
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803